Drug & supplement interaction

Fasting + Mobocertinib Succinate

Mobocertinib Succinate brand name: Exkivity.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 20, 2026
The bottom line No known interaction

We found no known interaction between Fasting and Mobocertinib Succinate in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone interested in this? Share
Facebook Post Reddit Email
On this page
Interaction report

Fasting and Mobocertinib Succinate

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Mobocertinib Succinate and Fasting in our sources. This does not guarantee that the combination is completely free of risk — research on Fasting alongside specific medications may be limited.

Fasting is an eating pattern rather than something you take. Ask your pharmacist or doctor before changing how you eat while on a prescribed medicine: some medicines are dosed around meals, and a change in diet can change how they work. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Fasting safety at a glance

Fasting overall Use caution Often tolerated by healthy adults but can be risky for some people and medications.
Pregnancy Avoid Prolonged or strict fasting is generally discouraged during pregnancy without medical supervision.
Breastfeeding Use caution May affect hydration, energy, and possibly milk supply, so check with your provider first.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Mobocertinib Succinate and Fasting? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Mobocertinib Succinate

Interactions in our licensed database are recorded against drug classes, not just single drug names. Mobocertinib Succinate is filed under 3 classifications — qt interval-prolonging drugs, cytochrome p450 3a4 (cyp3a4) substrates, oral drugs. Fasting has documented interactions with 4 drug classes — the most serious being warfarin (coumadin) (major), anticoagulant/antiplatelet drugs (moderate) and antidiabetes drugs (moderate) — and none of Mobocertinib Succinate’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Fasting Does Interact With Other Medications

Fasting has 2 major, 206 moderate known drug interactions in our database — Mobocertinib Succinate isn’t one of them. If you take anything else, check it against the full list below.

Major 2 Moderate 206 No known interaction 2,622 (incl. Mobocertinib Succinate)
Taking anything else?

Check Another of Your Medications Against Fasting

Covers the 2,830 medications we’ve checked against Fasting. Pick one to open its full report.

What to actually watch for

What Fasting Itself Has Been Linked To

This is not an interaction — nothing below involves Mobocertinib Succinate. It is the side-effect record for Fasting on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Fasting, this list is the first place to look. 3 entries are worth acting on rather than waiting out — marked below.

  • Dehydration / An irregular heartbeat / Raised blood pressure Worth acting on Additional detail

    “Dehydration resulting in headache, increased blood pressure, and fever has occurred rarely with medically supervised water-only fasting. Palpitations have occurred rarely. Medically supervised very low-calorie fasting has resulted rarely in mild transitory arrhythmia.”

    Fasting · Natural Medicines adverse-effect record, reported in arrhythmia.

    2 sources cited
    1. 102755. Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018;18(1):67. PubMed
    2. 102753. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
  • Low sodium Worth acting on Additional detail

    “Hyponatremia has occurred rarely with medically supervised water-only fasting. Transitory hypoglycemia and bleeding gums have occurred rarely with medically supervised very low-calorie fasting.

    Hypoglycemia or hyperglycemia are not more common with intermittent fasting when compared with continuous energy restriction.”

    Fasting · Natural Medicines adverse-effect record, reported in hypoglycemia.

    4 sources cited
    1. 102755. Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018;18(1):67. PubMed
    2. 102753. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
    3. 102736. Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with Type 2 diabetes: A randomized noninferiority trial. JAMA Netw Open. 2018;1(3):e180756. PubMed
    4. 108366. He S, Wang J, Zhang J, Xu J. Intermittent versus continuous energy restriction for weight loss and metabolic improvement: A meta-analysis and systematic review. Obesity (Silver Spring) 2021;29(1):108-115. PubMed
  • Low blood sugar / High blood sugar / Bleeding or bruising Worth acting on Additional detail

    Recorded for Fasting in the same Natural Medicines adverse-effect record shown under Low sodium above.

  • Mood changes or irritability Additional detail

    “Medically supervised water-only fasting has resulted in fatigue in about 50% of patients. Insomnia, lightheadedness, and headache were also fairly common. Medically supervised very low-calorie fasting has also resulted rarely in cold sensitivity, headache, dizziness, blurred vision, fatigue, and sleep disturbance.

    Headache, reduced energy, sleep disturbance, cold sensitivity, dizziness, lightheadedness, irritability,…”

    Fasting · Natural Medicines adverse-effect record, reported in cluster headache.

    6 sources cited
    1. 102755. Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018;18(1):67. PubMed
    2. 102753. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
    3. 102737. Tinsley GM, Moore ML, Graybeal AJ, et al. Time-restricted feeding plus resistance training in active females: a randomized trial. Am J Clin Nutr. 2019;110(3):628-640. PubMed
    4. 102741. Cioffi I, Evangelista A, Ponzo V, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):371. PubMed
    5. 102742. Schübel R, Nattenmüller J, Sookthai D, et al. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. Am J Clin Nutr. 2018;108(5):933-945. PubMed
    6. 102744. Sundfør TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial. Nutr Metab Cardiovasc Dis. 2018;28(7):698-706. PubMed
  • Bloating or gas Additional detail

    “Medically supervised water-only fasting has resulted in nausea in about 32% of patients. Dyspepsia, abdominal pain, diarrhea, and vomiting have occurred less commonly. Vomiting, nausea, diarrhea, dyspepsia, bloating, bad breath, and dry mouth have also occurred rarely with medically supervised very low-calorie fasting.

    The main adverse effect of the intermittent fasting diet is hunger, which generally resolves with t…”

    Fasting · Natural Medicines adverse-effect record, reported in constipation.

    6 sources cited
    1. 102755. Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018;18(1):67. PubMed
    2. 102753. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
    3. 102741. Cioffi I, Evangelista A, Ponzo V, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):371. PubMed
    4. 102748. Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2018;75(1):65-72. PubMed
    5. 108359. Li C, Xing C, Zhang J, Zhao H, Shi W, He B. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome. J Transl Med 2021;19(1):148. PubMed
    6. 108366. He S, Wang J, Zhang J, Xu J. Intermittent versus continuous energy restriction for weight loss and metabolic improvement: A meta-analysis and systematic review. Obesity (Silver Spring) 2021;29(1):108-115. PubMed
  • Hair loss Additional detail

    “Medically supervised very low-calorie fasting has resulted rarely in skin rash.

    Hair loss has been reported in clinical trials of intermittent fasting.”

    Fasting · Natural Medicines adverse-effect record, reported in alopecia.

    2 sources cited
    1. 102753. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
    2. 102746. Harris L, McGarty A, Hutchison L, Ells L, Hankey C. Short-term intermittent energy restriction interventions for weight management: a systematic review and meta-analysis. Obes Rev. 2018;19(1):1-13. PubMed

Showing the 10 most notable of 27 recorded effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

Everything above comes from the Natural Medicines adverse-effect record for Fasting — expand a row for the licensed statement it rests on. We haven’t matched Mobocertinib Succinate to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Mobocertinib Succinate.

Everything else you take

See Every Supplement That Interacts With Mobocertinib Succinate

This page covers Fasting only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Mobocertinib Succinate page lists 146 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Cesium (major) and Ephedra (major).

By severity: 8 major · 98 moderate · 40 minor.

From our pharmacist’s overview on the Mobocertinib Succinate page

“Mobocertinib (Exkivity) is a targeted therapy for a hard-to-treat lung cancer, which makes dosing precision matter and this list worth real caution. Most of the 146 supplements on file can shift the drug's blood level, because mobocertinib is cleared by CYP3A4, an enzyme many botanicals speed up or slow down.”

Reviewed by 2 · Jul 18, 2026

Open the Mobocertinib Succinate interaction page

How much people look this up

Where Fasting and Mobocertinib Succinate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Fasting
Top half

#560 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Mobocertinib Succinate
Steady interest

#2,517 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Fasting reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Fasting and Mobocertinib Succinate records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Eating pattern

About Fasting

What is Fasting?

  • Weight loss
  • Blood sugar control
  • Heart health
  • Religious or spiritual practice
  • General wellness and longevity

Fasting means voluntarily going without food (and sometimes drink) for set periods. Some research suggests it may help with weight loss and blood sugar in certain people, but results vary and quality of evidence is mixed. It is not safe for everyone, so check with your doctor or pharmacist before starting—especially if you take medication or have a health condition.

Not applicable (a dietary practice, not a substance) · Time-restricted eating, alternate-day fasting, periodic multi-day fasts, intermittent fasting (e.g., 16:8 or 5:2), religious fasting

An interaction check asks whether these two react with each other — it does not ask whether Fasting is a good idea for someone in your situation. Here is what our Fasting record says about it on its own.

Fasting: dosing

There is no single "correct" fasting schedule, and no standardized dose. Popular approaches include daily time-restricted eating (such as a 16:8 pattern), the 5:2 plan, and alternate-day fasting. The best choice depends on your health, lifestyle, and goals.If you are new to fasting, it's wise to start gently—such as a slightly shorter eating window—and to drink plenty of water during fasting periods (unless your fast restricts fluids for religious reasons).

From our Fasting monograph — the full record covers uses, side effects and every documented interaction.

Read the full Fasting monograph & all interactions
Medication

About Mobocertinib

What Is Mobocertinib Used For?

Brand name: Exkivity

  • Mobocertinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that cannot be removed by surgery and has spread to other parts of the body either during or after treatment with platinum chemotherapy medications. Mobocertinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors.

See full Mobocertinib drug information
Keep checking

Other Drugs & Fasting

Browse every other medication we’ve checked against Fasting — both the ones with a known interaction and the ones without. Select any drug for the full detail.

2Major
206Moderate
0Minor
2,621No known interaction
2 Major 206 Moderate 2,621 No interaction
Major

2 interactions

Moderate

206 interactions

Showing 60 of 206 moderate interactions — see all 206 on the Fasting page.

No interaction 2,621 drugs checked — show the list

We also checked Fasting against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,621 medications checked with no known interaction — see the full Fasting list.

See the full Fasting interactions page
See every supplement checked against Mobocertinib Succinate, ranked by severity
Evidence & sources

Fasting References

The 23 references that drive our Fasting monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with Type 2 diabetes: A randomized noninferiority trial. JAMA Netw Open. 2018;1(3):e180756. PubMed
  2. Tinsley GM, Moore ML, Graybeal AJ, et al. Time-restricted feeding plus resistance training in active females: a randomized trial. Am J Clin Nutr. 2019;110(3):628-640. PubMed
  3. Cioffi I, Evangelista A, Ponzo V, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):371. PubMed
  4. Schübel R, Nattenmüller J, Sookthai D, et al. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. Am J Clin Nutr. 2018;108(5):933-945. PubMed
  5. Sundfør TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial. Nutr Metab Cardiovasc Dis. 2018;28(7):698-706. PubMed
  6. Harris L, Hamilton S, Azevedo LB, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep. 2018;16(2):507-547. PubMed
  7. Harris L, McGarty A, Hutchison L, Ells L, Hankey C. Short-term intermittent energy restriction interventions for weight management: a systematic review and meta-analysis. Obes Rev. 2018;19(1):1-13. PubMed
  8. Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2018;75(1):65-72. PubMed
  9. Chowdhury A, Khan H, Lasker SS, Chowdhury TA. Fasting outcomes in people with diabetes and chronic kidney disease in East London during Ramadan 2018: The East London diabetes in Ramadan survey. Diabetes Res Clin Pract. 2019;152:166-170. PubMed
  10. Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353. PubMed
  11. Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018;18(1):67. PubMed
  12. Katada Y, Nakagawa S, Nishimura A, et al. Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery. Eur J Clin Pharmacol. 2019;75(4):561-568. PubMed
  13. Lai YF, Cheen MHH, Lim SH, et al. The effects of fasting in Muslim patients taking warfarin. J Thromb Haemost. 2014;12(3):349-54. PubMed
  14. Grajower MM, Horne BD. Clinical management of intermittent fasting in patients with diabetes mellitus. Nutrients. 2019;11(4):873. PubMed
  15. Ibrahim M, Davies MJ, Ahmad E, et al. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Res Care. 2020;8(1):e001248. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Following Fasting While Taking Mobocertinib Succinate: Common Questions

Is it safe to follow Fasting while taking Mobocertinib Succinate?
We do not list a known interaction between Fasting and Mobocertinib Succinate. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the Fasting and Mobocertinib Succinate combination checked?
Interactions in our licensed database are recorded against drug classes. Mobocertinib Succinate is filed under 3 classifications, and Fasting has documented interactions with 4 drug classes — none of Mobocertinib Succinate's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Fasting interact with any other medications?
Yes. Fasting has 208 documented drug interactions in our database — Mobocertinib Succinate is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Mobocertinib Succinate interact with any supplements?
Yes. Mobocertinib Succinate has documented interactions with 146 supplements in our database — Fasting is not one of them. The Mobocertinib Succinate interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Fasting monograph Uses, safety profile, and every drug interaction in one place Mobocertinib drug information The full plain-English guide to this medication Mobocertinib Succinate supplement interactions Every supplement checked against Mobocertinib Succinate, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 23 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Mobocertinib Succinate and Fasting?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.